Ghosh is at the helm of the HUMANOID™ Center for Excellence at the University of California San Diego, which is pioneering ...

The phase III trial of reldesemtiv did not meet ... lateral sclerosis (ALS), but its findings shed light on ALS clinical research. From baseline to week 24, the mean group difference on the ...